March 8 (Reuters) – Cadila Healthcare Ltd: * UNIT ZYDUS PARTNERS WITH MEDICURE TO LAUNCH ITS NDA PRODUCT, ZYPITAMAG (PITAVASTATIN) IN U.S. Source text – bit.ly/2oYA0Yx Further company coverage: Our Standards:The Thomson Reuters Trust Principles. Powered by WPeMatico
The post BRIEF-Cadila Healthcare’s Zydus Partners With Medicure To Launch Zypitamag In U.S. appeared first on Dr. Kianor Shah - Professional Speaker, Dentist, Implant Surgeon, Fintech Expert, Entrepreneur.